Muscle Weakness due to ALS Treatment
There is no cure for amyotrophic lateral sclerosis. Treatment for amyotrophic lateral sclerosis includes medications that slow the progression of muscle weakness. Additional treatment is directed at medications that control the complications of amyotrophic lateral sclerosis, such as muscle spasms, constipation, fatigue, excessive salivation, pain, and depression. As the disease progresses, a person with amyotrophic lateral sclerosis eventually require significant supportive care. Mechanical ventilation may be required when the person is too weak to breathe.
Treatment for amyotrophic lateral sclerosis may include:
Muscle Weakness due to ALS Questions For Doctor
The following are some important questions to ask before and after the treatment of an amyotrophic lateral sclerosis.
Questions to ask before treatment:
- What are my treatment options?
- What are the risks associated with treatment?
- Do I need to stay in the hospital?
- How long will I be in the hospital?
- What are the complications I should watch for?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- When can I resume my normal activities?
- When can I return to work?
- Do I need a special exercise program?
- Will I need physical therapy?
- Will I need occupational therapy?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
Muscle Weakness due to ALS Specialist
Physicians from the following specialties evaluate and treat amyotrophic lateral sclerosis:
Continue to Muscle Weakness due to ALS Home Care
- Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases J Neurol Sci 1994; 124: 96-107. 
- Brown RC, Lockwood AH, Sonawane BR. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect. 2005 Sep;113(9):1250-6. 
- Waragai M: MRI and clinical features in amyotrophic lateral sclerosis. Neuroradiology 1997; 39: 847-851.